Related Experiment Video
Updated: Sep 20, 2026
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Cost-effectiveness of stroke prevention
1Department of Social Medicine, University of Bristol, UK.
Insights
Economic evaluations show that aspirin and antiplatelet drugs are cost-effective for stroke prevention. Lifestyle modifications and targeted risk factor management offer significant health gains but require better implementation strategies.
Area of Science:
- Public Health
- Health Economics
- Preventive Medicine
Background:
- Stroke is a significant, preventable public health burden.
- Economic appraisal of interventions is crucial for efficient resource allocation in healthcare.
- Understanding the cost-effectiveness of various stroke prevention strategies is essential.
Purpose of the Study:
- To evaluate the economic viability of different interventions for stroke prevention.
- To compare the cost-effectiveness of pharmacological treatments, surgical procedures, and lifestyle modifications.
- To identify strategies that offer the greatest reduction in stroke burden for the lowest cost.
Main Methods:
- Review of existing cost-effectiveness analyses for stroke prevention interventions.
- Analysis of data on the efficacy, cost, and resource implications of treatments like anticoagulation, antiplatelet drugs, and carotid endarterectomy.
- Assessment of evidence for lifestyle modifications and cardiovascular risk factor management.
Main Results:
- Aspirin and antiplatelet drugs demonstrate high cost-effectiveness for secondary stroke prevention.
- Anticoagulation for non-rheumatic atrial fibrillation is effective but less cost-effective than aspirin alone.
- Carotid endarterectomy shows poor value for money, though predictive models may improve its cost-effectiveness.
- Modification of major cardiovascular risk factors (cholesterol, blood pressure, smoking) is highly cost-effective.
Conclusions:
- Pharmacological interventions, particularly antiplatelet therapy, are cost-effective for stroke prevention.
- Lifestyle modifications and targeted cardiovascular risk factor management hold significant potential for health gain but require improved implementation.
- Further research is needed to enhance the cost-effectiveness of surgical interventions and lifestyle-based strategies.
Abstract:
Stroke is a preventable disease and there are several interventions that might have an important role in reducing the burden of disease. Economic appraisal of these different interventions is essential as resources are scarce and it is logical to attempt to obtain the greatest reduction in disease for the lowest cost. Anticoagulation for non-rheumatic atrial fibrillation is highly effective, but is expensive and cost-effectiveness analyses show that use of aspirin alone would prevent almost as many strokes at much lower cost. Antiplatelet drugs are both effective and inexpensive and their use in secondary prevention would potentially save the NHS about 900 Pounds per life year gained. Carotid endarterectomy and the associated screening costs are poor value for money but recent attempts to use predictive models to determine which patients will benefit from surgery may improve its cost-effectiveness. Current evidence is dominated by pharmacological interventions and much less good evidence is available for life-style modifications such as dietary change and physical exercise. Modification of major cardiovascular risk factors (blood cholesterol, high blood pressure and smoking) is very cost-effective but needs to be better targeted if potential health gain is to be realised.
Related Concept Videos
01:26Atherosclerosis III: Management
01:23Atherosclerosis IV: Nursing Management